Dear Ultrasound Insider,
Transabdominal ultrasound is a noninvasive, convenient imaging modality that's increasingly being used to diagnose intestinal ailments because it can visualize intestinal wall thickness, the extent and blood flow of lesions, and the shape of the intestinal cavity. But it can be difficult for 2D ultrasound to differentiate between two common intestinal diseases that have similar clinical features: inflammatory bowel disease (IBD) and colon cancer.
Contrast-enhanced ultrasound (CEUS) could be the solution, offering clinicians an effective tool for distinguishing between IBD and colon cancer, according to researchers from Peking University Third Hospital in Beijing. Learn more about the diagnostic potential of CEUS for this clinical problem in our Insider Exclusive.
When you've read our featured article, take a look at what else is going on in the Ultrasound Community:
- Is ultrasound elastography for liver evaluation worth the cost? Find out what Emory University researchers discovered.
- Learn how artificial intelligence can bridge the experience gap for liver CEUS.
- Read why a research team from Tripler Army Medical Center in Honolulu believes that teleultrasound can be an effective way to provide prenatal care to women in medically underserved areas.
- Can deep learning prevent unnecessary thyroid biopsies? Discover why researchers from Minnesota and Arizona say yes.
- Get the scoop on technology that transforms ultrasound from 2D to 3D -- for the cost of a $10 microchip.
- Finally, read our story about a $2,000 ultrasound probe for iPhones that was recently cleared by the U.S. Food and Drug Administration.
If you have a comment or report to share about any aspect of ultrasound imaging, I invite you to contact me.
